Topic

Visiox Pharma

1 article

SPARC licences development, commercialisation rights of PDP-716, SDN-037 to Visiox Pharma
News 9 Dec 2021

SPARC licences development, commercialisation rights of PDP-716, SDN-037 to Visiox Pharma

The company will receive equity in Visiox along with other financial considerations Sun Pharma Advanced Research Company (SPARC) has entered…